Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survival

Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies

(2013)   ANNALS OF INTERNAL MEDICINE

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel

(2011) C C Uzoh et al.   BRITISH JOURNAL OF CANCER

Physical Activity and Survival After Prostate Cancer Diagnosis in the Health Professionals Follow-Up Study

(2011) Stacey A. Kenfield et al.   JOURNAL OF CLINICAL ONCOLOGY

Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model

(2011) Ashley Gray et al.   JOURNAL OF ENDOCRINOLOGY

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial

(2011) James W Denham et al.   LANCET ONCOLOGY

Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer

(2010) J. Flanagan et al.   ANNALS OF ONCOLOGY

Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study

(2009) Jonathan L. Wright et al.   CANCER CAUSES & CONTROL

The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes

(2009) Swapnil N. Rajpathak et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Adipose tissue as an endocrine organ

(2009) Sandra Galic et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Intermittent Calorie Restriction Delays Prostate Tumor Detection and Increases Survival Time in TRAMP Mice

(2009) Melissa J. L. Bonorden et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Biological and Technical Variables Affecting Immunoassay Recovery of Cytokines from Human Serum and Simulated Vaginal Fluid: A Multicenter Study

(2008) Raina N. Fichorova et al.   ANALYTICAL CHEMISTRY

Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer

(2008) Matthew R. Smith et al.   CANCER

Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men

(2008) M. S. Lewitt et al.   DIABETOLOGIA

Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis

(2008) Mari-Anne Rowlands et al.   INTERNATIONAL JOURNAL OF CANCER

Insulin-Like Growth Factor Binding Protein 1 as a Novel Specific Marker of Hepatic Insulin Sensitivity

(2008) Anna Kotronen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

(2008) Howard I. Scher et al.   JOURNAL OF CLINICAL ONCOLOGY